| Ident. | Authors (with country if any) | Title |
|---|
| 000009 (2021) |
Rashed Noor [Bangladesh] | Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic. |
| 000031 (2021) |
Hülya Gamze Çelik [Turquie] ; Iran Keske [Turquie] ; Ülker Ener [Turquie] ; Müge Tekba [Turquie] ; Mahir Kapmaz [Turquie] ; Krü Taylan Ahin [Turquie] ; Asl Özy Ld R M [Turquie] ; Saide Aytekin [Turquie] ; Vedat Aytekin [Turquie] ; Önder Ergönül [Turquie] | Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic? |
| 000041 (2021) |
Keenan M. Mahan [États-Unis] ; Bryan D. Hayes [États-Unis] ; Crystal M. North [États-Unis] ; Justin S. Becker [États-Unis] ; Andrew Z. Fenves [États-Unis] ; Guibenson Hyppolite [États-Unis] ; Sara Khosrowjerdi [États-Unis] ; Daniel Sinden [États-Unis] ; Dana A. Stearns [États-Unis] | Utility of Hypertonic Saline and Diazepam in COVID-19-Related Hydroxychloroquine Toxicity. |
| 000056 (2021) |
Jessica S C. Leung [Hong Kong] ; Maurice M W. Cheng [Nouvelle-Zélande] | Trust in the time of corona: epistemic practice beyond hard evidence. |
| 000063 (2021) |
Jennie H. Best [États-Unis] ; Amanda M. Kong [États-Unis] ; Emma Kaplan-Lewis [États-Unis] ; Otis W. Brawley [États-Unis] ; Rachel Baden [États-Unis] ; James L. Zazzali [États-Unis] ; Karen S. Miller [États-Unis] ; James Loveless [États-Unis] ; Krutika Jariwala-Parikh [États-Unis] ; Shalini V. Mohan [États-Unis] | Treatment Patterns in US Patients Hospitalized With COVID-19 and Pulmonary Involvement. |
| 000077 (2021) |
Muhammad Sani Ismaila [Trinité-et-Tobago] ; Faruku Bande [Nigeria] ; Aminu Ishaka [Nigeria] ; Aminatu Abubakar Sani [Nigeria] ; Karla Georges [Trinité-et-Tobago] | Therapeutic options for COVID-19: a quick review. |
| 000083 (2021) |
Nurdan Kokturk [Turquie] ; Cenk Babayigit [Turquie] ; Seval Kul [Turquie] ; Pelin Duru Cetinkaya [Turquie] ; Sibel Atis Nayci [Turquie] ; Serap Argun Baris [Turquie] ; Oguz Karcioglu [Turquie] ; Pinar Aysert [Turquie] ; Ilim Irmak [Turquie] ; Aycan Akbas Yuksel [Turquie] ; Yonca Sekibag [Turquie] ; Oya Baydar Toprak [Turquie] ; Emel Azak [Oman] ; Sait Mulamahmutoglu [Turquie] ; Caglar Cuhadaroglu [Turquie] ; Aslihan Demirel [Turquie] ; Bugra Kerget [Turquie] ; Burcu Baran Ketencioglu [Turquie] ; Hasan Selcuk Ozger [Turquie] ; Gulcihan Ozkan [Turquie] ; Zeynep Ture [Turquie] ; Begum Ergan [Turquie] ; Vildan Avkan Oguz [Turquie] ; Oguz Kilinc [Turquie] ; Merve Ercelik [Turquie] ; Tansu Ulukavak Ciftci [Turquie] ; Ozlem Alici [Turquie] ; Esra Nurlu Temel [Turquie] ; Ozlem Ataoglu [Turquie] ; Asena Aydin [Turquie] ; Dilek Cetiner Bahcetepe [Turquie] ; Yusuf Taha Gullu [Turquie] ; Fusun Fakili [Turquie] ; Figen Deveci [Turquie] ; Neslihan Kose [Turquie] ; Muge Meltem Tor [Turquie] ; Gulsah Gunluoglu [Turquie] ; Sedat Altin [Turquie] ; Teyfik Turgut [Turquie] ; Tibel Tuna [Turquie] ; Onder Ozturk [Turquie] ; Oner Dikensoy [Turquie] ; Pinar Yildiz Gulhan [Turquie] ; Ilknur Basyigit [Turquie] ; Hasim Boyaci [Turquie] ; I Kivilcim Oguzulgen [Turquie] ; Sermin Borekci [Turquie] ; Bilun Gemicioglu [Turquie] ; Firat Bayraktar [Turquie] ; Osman Elbek [Turquie] ; Ismail Hanta [Turquie] ; Hacer Kuzu Okur [Turquie] ; Gulseren Sagcan [Turquie] ; Oguz Uzun [Turquie] ; Metin Akgun [Turquie] ; Goksel Altinisik [Turquie] ; Berna Dursun [Turquie] ; Ebru Cakir Edis [Turquie] ; Erkmen Gulhan [Turquie] ; Fusun Oner Eyuboglu [Turquie] ; Okkes Gultekin [Turquie] ; Yavuz Havlucu [Turquie] ; Metin Ozkan [Turquie] ; Aysin Sakar Coskun [Turquie] ; Abdullah Sayiner [Turquie] ; Ali Fuat Kalyoncu [Turquie] ; Oya Itil [Turquie] ; Hasan Bayram [Turquie] | The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients. |
| 000084 (2021) |
Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis] | The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review. |
| 000114 (2021) |
Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis] | Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection. |
| 000166 (2021) |
Giulia Fiscon [Italie] ; Federica Conte [Italie] ; Lorenzo Farina [Italie] ; Paola Paci [Italie] | SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. |
| 000169 (2021) |
Bianca D. Balmant [Brésil] ; Raquel S. Torrinhas [Brésil] ; Ilanna M. Rocha [Brésil] ; Danielle C. Fonseca [Brésil] ; Francisco F C. Formiga [Brésil] ; Eloisa S D O. Bonfá [Brésil] ; Eduardo F. Borba [Brésil] ; Dan L. Waitzberg [Brésil] | SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link? |
| 000170 (2021) |
Filipa Silva [Portugal] ; Ana Cipriano [Portugal] ; Hugo Cruz [Portugal] ; Joana Tavares [Portugal] ; Joana Fragoso [Portugal] ; Jorge Malheiro [Portugal] ; Manuela Almeida [Portugal] ; La Salete Martins [Portugal] ; Miguel Abreu [Portugal] ; Sofia Pedroso [Portugal] ; Leonídio Dias [Portugal] ; Ant Nio Castro Henriques [Portugal] | SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases. |
| 000188 (2021) |
Veronique Michaud [États-Unis, Canada] ; Pamela Dow [États-Unis] ; Sweilem B. Al Rihani [États-Unis] ; Malavika Deodhar [États-Unis] ; Meghan Arwood [États-Unis] ; Brian Cicali [États-Unis] ; Jacques Turgeon [États-Unis, Canada] | Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs. |
| 000233 (2021) |
Olfa Noureddine [Tunisie] ; Noureddine Issaoui [Tunisie] ; Mouna Medimagh [Tunisie] ; Omar Al-Dossary [Arabie saoudite] ; Houda Marouani [Tunisie] | Quantum chemical studies on molecular structure, AIM, ELF, RDG and antiviral activities of hybrid hydroxychloroquine in the treatment of COVID-19: Molecular docking and DFT calculations. |
| 000265 (2021) |
Gayathri Baburaj [Inde] ; Levin Thomas [Inde] ; Mahadev Rao [Inde] | Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies. |
| 000270 (2021) |
Enrico Scala [Italie] ; Luca Fania [Italie] ; Filippo Bernardini [Italie] ; Rodolfo Calarco [Italie] ; Sabrina Chiloiro [Italie] ; Cristiana Di Campli [Italie] ; Sabrina Erculei [Italie] ; Mauro Giani [Italie] ; Marzia Giordano [Italie] ; Annarita Panebianco [Italie] ; Francesca Passarelli [Italie] ; Andrea Trovè [Italie] ; Sofia Verkhovskaia [Italie] ; Giandomenico Russo [Italie] ; Antonio Sgadari [Italie] ; Biagio Didona [Italie] ; Damiano Abeni [Italie] | Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature. |
| 000277 (2021) |
Gustavo José Da Silva Pereira [Brésil] ; Anderson Henrique França Figueredo Leão [Brésil] ; Adolfo Garcia Erustes [Brésil] ; Ingrid Beatriz De Melo Morais [Brésil] ; Talita Aparecida De Moraes Vrechi [Brésil] ; Lucas Dos Santos Zamarioli [Brésil] ; Cássia Arruda Souza Pereira [Brésil] ; Laís De Oliveira Marchioro [Brésil] ; Letícia Paulino Sperandio [Brésil] ; Ísis Valeska Freire Lins [Brésil] ; Mauro Piacentini [Italie] ; Gian Maria Fimia [Italie] ; Patrícia Reckziegel [Brésil] ; Soraya Soubhi Smaili [Brésil] ; Claudia Bincoletto [Brésil] | Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19. |
| 000280 (2021) |
Ingrid Fricke-Galindo [Mexique] ; Ramcés Falfán-Valencia [Mexique] | Pharmacogenetics Approach for the Improvement of COVID-19 Treatment. |
| 000295 (2021) |
Zheng Zequn [République populaire de Chine] ; Wu Yujia [République populaire de Chine] ; Qian Dingding [République populaire de Chine] ; Lian Jiangfang [République populaire de Chine] | Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. |
| 000306 (2021) |
Pobitra Borah [Inde] ; Pran Kishore Deb [Jordanie] ; Balakumar Chandrasekaran [Jordanie] ; Manoj Goyal [Arabie saoudite] ; Monika Bansal [Arabie saoudite] ; Snawar Hussain [Arabie saoudite] ; Pottathil Shinu [Arabie saoudite] ; Katharigatta N. Venugopala [Afrique du Sud] ; Nizar A. Al-Shar'I [Jordanie] ; Satyendra Deka [Inde] ; Vinayak Singh [Afrique du Sud] | Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. |
| 000307 (2021) |
Shweta A. More [Inde] ; Akshay S. Patil [États-Unis] ; Nikhil S. Sakle [Inde] ; Santosh N. Mokale [Inde] | Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs. |
